Data Availability
Datasets used will be available at reasonable request from the corresponding author.
References
Mathew G, George AS, Deepthi RV et al (2023) Epidemiology and outcomes of pneumococcal sepsis in children with nephrotic syndrome in a developing country. Pediatr Nephrol 38:131–137. https://doi.org/10.1007/s00467-022-05550-0
Amicizia D, Astengo M, Paganino C et al (2022) Economic burden of pneumococcal disease in children in Liguria, Italy. Hum Vaccines Immunother 18:2082205. https://doi.org/10.1080/21645515.2022.2082205
Adamu AL, Karia B, Bello MM et al (2022) The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria. BMJ Glob Health 7:e007080. https://doi.org/10.1136/bmjgh-2021-007080
Krishnamoorthy Y, Eliyas SK, Nair NP et al (2019) Impact and cost effectiveness of pneumococcal conjugate vaccine in India. Vaccine 37:623–630. https://doi.org/10.1016/j.vaccine.2018.12.004
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mathew, G., Gracy, E. & Muliyil, D.E. Cost savings of pneumococcal vaccination in children with nephrotic syndrome in a low-middle-income country. Pediatr Nephrol (2024). https://doi.org/10.1007/s00467-024-06390-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00467-024-06390-w